Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Market Consolidation and Innovation in US Dialysis.

Publication ,  Journal Article
Erickson, KF; Warrier, A; Wang, V
Published in: Advances in chronic kidney disease
January 2022

While patients with end-stage kidney disease have benefited from innovations in clinical therapeutics and care delivery, these changes have been primarily incremental and have not fundamentally transformed care delivery. Dialysis markets are highly concentrated, which may impede innovation. Unique features of the dialysis industry that have contributed to consolidation can help to explain links between consolidation and innovation. We discuss these unique features and then provide a framework for considering the effects of consolidation on innovation in dialysis that focuses on the following economic considerations: (1) industry characteristics, composition, and stage of consolidation, (2) innovation characteristics and relative profitability, (3) the role of government regulation, and (4) innovation from smaller providers and new entrants. We present examples of how these considerations have influenced the adoption of alternative dialysis technologies such as peritoneal dialysis and erythropoietin-stimulating agents, and we discuss how consolidated markets can both help and hinder recent policy initiatives to transform dialysis care delivery. Only by considering these important drivers of consolidation, future efforts can be successful in transforming end-stage kidney disease care.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Advances in chronic kidney disease

DOI

EISSN

1548-5609

ISSN

1548-5595

Publication Date

January 2022

Volume

29

Issue

1

Start / End Page

65 / 75

Related Subject Headings

  • Urology & Nephrology
  • Renal Dialysis
  • Peritoneal Dialysis
  • Kidney Failure, Chronic
  • Humans
  • Delivery of Health Care
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Erickson, K. F., Warrier, A., & Wang, V. (2022). Market Consolidation and Innovation in US Dialysis. Advances in Chronic Kidney Disease, 29(1), 65–75. https://doi.org/10.1053/j.ackd.2022.01.002
Erickson, Kevin F., Anupama Warrier, and Virginia Wang. “Market Consolidation and Innovation in US Dialysis.Advances in Chronic Kidney Disease 29, no. 1 (January 2022): 65–75. https://doi.org/10.1053/j.ackd.2022.01.002.
Erickson KF, Warrier A, Wang V. Market Consolidation and Innovation in US Dialysis. Advances in chronic kidney disease. 2022 Jan;29(1):65–75.
Erickson, Kevin F., et al. “Market Consolidation and Innovation in US Dialysis.Advances in Chronic Kidney Disease, vol. 29, no. 1, Jan. 2022, pp. 65–75. Epmc, doi:10.1053/j.ackd.2022.01.002.
Erickson KF, Warrier A, Wang V. Market Consolidation and Innovation in US Dialysis. Advances in chronic kidney disease. 2022 Jan;29(1):65–75.
Journal cover image

Published In

Advances in chronic kidney disease

DOI

EISSN

1548-5609

ISSN

1548-5595

Publication Date

January 2022

Volume

29

Issue

1

Start / End Page

65 / 75

Related Subject Headings

  • Urology & Nephrology
  • Renal Dialysis
  • Peritoneal Dialysis
  • Kidney Failure, Chronic
  • Humans
  • Delivery of Health Care
  • 3202 Clinical sciences
  • 1103 Clinical Sciences